Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-06-01
著者
-
Abrams Paul
Bristol Urologic Institute
-
CARDOZO Linda
Department of Women's Health, King's College Hospital
-
SERDAREVIC Dzelal
Pfizer Global Research and Development
-
HARGREAVES Katherine
Pfizer Global Research and Development
-
CHAPPLE CHRISTOPHER
Department of Urology, Royal Hallamshire Hospital
-
KHULLAR VIKRAM
Department of Obstetrics and Gynaecology, Imperial College School of Medicine
-
Khullar Vikram
Department Of Obstetrics And Gynaecology Imperial College School Of Medicine
-
Chapple Christopher
Department Of Urology Royal Hallamshire Hospital
-
Cardozo Linda
Department Of Women's Health King's College Hospital
-
Cardozo Linda
Department Of Urogynaecology King's College Hospital
関連論文
- Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome
- Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome
- The Effect of Hormones on the Lower Urinary Tract
- SS2 LUTS/OAB
- IL3 Recent pharmacological treatment for overactive bladder (OAB) and its future perspective
- IL-11 (S) The Effect of Hormones on the Lower Urinary Tract